The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to ...

During last night’s game presented by Emory Healthcare, the Atlanta Hawks Foundation, together with the Ressler Gertz Family ...

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 13 at the Beards and Blue Ribbons Gala. The event, which starts at 6 p.m. at The Hall ...